State Street Corp Updates Altimmune Stake as of Dec 31, 2023
Ticker: ALT · Form: SC 13G/A · Filed: Jan 23, 2024 · CIK: 1326190
| Field | Detail |
|---|---|
| Company | Altimmune, Inc. (ALT) |
| Form Type | SC 13G/A |
| Filed Date | Jan 23, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**State Street Corp still holds Altimmune shares, signaling continued institutional interest.**
AI Summary
State Street Corp, a major financial institution, filed an amended SC 13G/A on January 23, 2024, indicating its ownership of Altimmune, Inc. common stock as of December 31, 2023. This filing updates their previous disclosure, showing their continued passive investment in the pharmaceutical company. This matters to investors because it confirms a large institutional holder maintains its position, which can signal confidence in Altimmune's long-term prospects.
Why It Matters
This filing shows that a significant institutional investor, State Street Corp, continues to hold shares in Altimmune, Inc., which can be a positive signal for other investors.
Risk Assessment
Risk Level: low — This is a routine update from a large institutional investor and does not indicate any immediate significant risk or opportunity.
Analyst Insight
Investors should note that State Street Corp continues to hold a position in Altimmune, Inc., suggesting ongoing institutional confidence. However, without specific share count changes, it's difficult to gauge the exact sentiment shift. Further analysis of the full filing would be needed to determine the percentage of ownership and any changes from previous filings.
Key Players & Entities
- State Street Corp (company) — the reporting person filing the SC 13G/A
- Altimmune, Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event which requires the filing of this statement
- January 23, 2024 (date) — the filing date of the SC 13G/A
- 02155H200 (other) — the CUSIP number for Altimmune, Inc. common stock
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as indicated by 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 EXIT FILING'.
Who is the reporting person in this filing?
The reporting person is State Street Corp, as stated under 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: STATE STREET CORP' and '1. NAME OF REPORTING PERSON: STATE'.
What is the subject company whose securities are being reported?
The subject company is Altimmune, Inc., as indicated by 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Altimmune, Inc.' and 'ALTIMMUNE INC (NAME OF ISSUER)'.
What is the date of the event that triggered this filing?
The date of the event which requires the filing of this statement is December 31, 2023, as specified by '12/31/2023 (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT)'.
Under which rule is this Schedule 13G filed?
This Schedule 13G is filed under Rule 13D-1 (B), as indicated by '(X) RULE 13D-1 (B)'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 23, 2024 regarding Altimmune, Inc. (ALT).